A Look At Middlemen Fees In 340B Drug Discount Program
On Oct. 23, the U.S Senate Committee on Health, Education, Labor and Pensions held a hearing on the 340B program, a controversial program that provides heavy discounts to qualifying providers that can...To view the full article, register now.
Already a subscriber? Click here to view full article